Published Sep 20, 2010

Richard Epstein on Regulation

Richard Epstein critiques the complexities of current regulatory frameworks, delving into the adverse effects of Keynesian economic policies and FDA regulations on economic growth and innovation, while questioning the efficacy of judicial review in mitigating these challenges.

Episode Highlights

Topics covered

Economic Theory and Policy
01
Pharmaceutical Regulation
02
Regulatory Burdens
03

Richard Epstein on Regulation

Topics covered

Popular Clips

FDA Controversy

Anxiety and Confidence

The Cost of FDA Regulations

The Limits of Keynesian Theory

The Impact of Litigation

The Perils of Jingoistic Regulation

Economic Stagnation

Shifting Balances

Misguided Regulations

Regulation Debate

Market Failure and Regulation

Fraud and Government Programs

The Economic Impact

The Challenge of Finding the Sweet Spot

Episode Highlights

Economic Theory and Policy

Pharmaceutical Regulation

Regulatory Burdens

Richard Epstein on Regulation

Topics covered

Popular Clips

Episode Highlights

Economic Theory and PolicyRichard Epstein critiques Keynesian economics, arguing it lacks a clear framework for balancing regulation and market forces. He also examines the impact of shifting policies and misguided regulations on economic stability.

Economic Theory and Policy

Pharmaceutical RegulationRichard Epstein examines the FDA's regulatory framework and its impact on the pharmaceutical industry. He critiques the agency's cautious approach, highlighting issues like off-label drug use and litigation challenges that hinder innovation.

Pharmaceutical Regulation

Regulatory BurdensRichard Epstein critiques the current regulatory environment, arguing that its unprecedented complexity imposes high costs on the economy. He explores the economic stagnation resulting from these regulations and the uncertain role of judicial review in addressing these challenges.

Regulatory Burdens